Академический Документы
Профессиональный Документы
Культура Документы
Azad Ahmed
MBA
Institute of Business Administration (IBA), Karachi
Pakistan
e-mail: azad.ahmed@iba.edu.pk.khi
Presentations Agenda
Literature review
Research Aim
Research Objectives
Methodology & Methods
Main Results & Findings
Papers Conclusion
New understandings
Literature Review
Pakistan has a very vibrant and forward looking Pharma
industry. At the time of independence in 1947, there was
hardly any pharma industry in the country. Today Pakistan
has about 400 pharmaceutical manufacturing units
including those operated by 25 multinationals present in
the country. The Pakistan Pharmaceutical Industry meets
around 70% of the country's demand of Finished Medicine.
The domestic pharma market, in term of share market is
almost evenly divided between the Nationals and the
Multinationals.
Source: PPMA (Pakistan Pharmaceutical
Manufacturers Association) website
http://www.ppma.org.pk/PPMAIndustry.aspx
Pakistan meets 80% of its domestic demand
of medicines from local production and 20%
through imports. The pharmaceuticals market
size is Rs. 70 Billion (US $ 1.2 Billion),
approximately. The market for
pharmaceuticals in Pakistan has been
expanding at a rate of around 10 to15% since
last few years.
(Subzwari & Khan, Spring 2009)
The number of pharmaceutical units
set up in different provinces of
Pakistan are as under:
UNITS LICENSES
PROVINCE N NMC TOTAL FOR BM/SM RP TOTAL
Punjab 191 05 196 191 13 2 206
Sindh 86 23 109 106 16 0 122
NWFP 43 00 43 43 00 0 43
Balochistan 05 02 07 06 01 0 07
AJK 03 00 03 03 00 0 03
Total 328 30 358 349 30 2 381
N=National For=Formulation RP=Repacking MNC=Multi National Company
BM=Basic Manufacture SM=Semi Basic Manufacture
Presently 358 pharmaceutical manufacturing
units including 30 of multinational origin are
producing drugs. The major players in this
sector are the multinational companies
accounting for almost 55% of the
pharmaceutical business in Pakistan.
(Memon, 2009).
The total medicine sales in Pakistan was of
the order of Rs. 136 billion in 2009 projected
to increase by 10% to Rs. 154 billion in 2009
(Business Monitor International [BMI], 2009).
Pakistan meets 80% of its demand from local
production while 20% of the medicines are
imported. The local production however is
largely dependent on imported raw materials
as almost no raw materials are produced
locally (Pervez, 2008).
Research Aim